A role for TRPC6 in primary glomerular disease processes was first suggested by Reiser and colleagues [62], who demonstrated that TRPC6 was upregulated in microdissected glomeruli in human kidney biopsy specimens from patients with MGN and MCD, with a similar trend in patients with FSGS. Here, TRPC6 is linked to idiopathic membranous glomerulonephritis.